[Occurrence and histological structure of adenocarcinoma of the endocervix after long-term use of oral contraceptives (author's transl)].
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000473:pathology; D000328:Adult; D002278:Carcinoma in Situ / Q000139:chemically induced; D002454:Cell Differentiation; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects; D009644:Norgestrel / Q000009:adverse effects; D010298:Parity; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced* / Q000473:pathology
D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D009644:Norgestrel; D008234:Lynestrenol; D009640:Norethindrone
Vorkommen und histologische Struktur des Adenokarzinoms der Zervix-schleimhaut nach langjähriger Einnahme von Ovulationshemmern.